cover image: Percutaneous radiofrequency ablation for treatment of hepatocellular carcinoma

Premium

20.500.12592/z98xrx

Percutaneous radiofrequency ablation for treatment of hepatocellular carcinoma

18 Jan 2010

Report Number 39 . [...] D. Anderson  Raut et al. study had a larger sample size and  Cancer Center, Houston, US; and the G.  longer follow‐up time.  Pascale National Cancer Institute,  Fondazione, Italy          Yan46 (1999‐2006)  Chen49 (1999‐2005);  Peking University school of Oncology,  Yan et al. study had a 5‐year follow‐up, while  Chen50 (2000‐2007);  Beijing Cancer Hospital & Institute,  others have 3‐year follow‐ [...] Local: 3 (3); distant 34(33).    No procedure related mortality. 3 (2)  (2008)  major complications; 3(2) minor  complications.  47   SRS  97  93  81      Overall: 23 (37). [...] Local: 0(0); distant 23 (37).    No procedure related mortality. 2 (3)  major complications; no minor  complications.                          1 y  3y  5y            Helmberger   TACE+PRFA  94*  65*  27*  P<0.01  NA    NA  32 (2007)  TACE  57*  15*  6*  Ref    NA    NA    SRS  78*  53*  29*  P<0.01  NA    NA                          1y  3y  5y            Liu46 (2007)  TACE+PRFA  75  37  ‐‐  1st y:
health science and technology research cancer medical research medicine health care medical specialisation randomized controlled trial liver meta-analysis therapy carcinoma, hepatocellular clinical medicine health treatment health sciences medical specialties diseases and conditions ci catheter ablation hepatocellular carcinoma liver cancers radiofrequency ablation hepatocellular  carcinoma chemoembolization radio frequency ablation hepatocellular cancer liver cancer hepatocellular carcinoma transarterial chemoembolization

Authors

Xie, Xuanqian

Pages
61
Published in
Canada

Related Topics

All